 | B. Riley Raises Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $174.00
www.americanbankingnews.com - May 22 at 8:17 AM |
| Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Short Interest Update
www.americanbankingnews.com - May 15 at 6:36 AM |
| Madrigal Pharmaceuticals Inc Expected to Post Q2 2020 Earnings of ($2.47) Per Share (NASDAQ:MDGL)
www.americanbankingnews.com - May 14 at 9:55 AM |
| Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 13 at 2:54 AM |
| Madrigal Pharmaceuticals (NASDAQ:MDGL) Releases Quarterly Earnings Results, Misses Estimates By $0.40 EPS
www.americanbankingnews.com - May 10 at 8:50 PM |
 | Was The Smart Money Right About Madrigal Pharmaceuticals (MDGL)?
finance.yahoo.com - May 10 at 3:40 PM |
| Analysts Expect Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) to Post -$2.09 EPS
www.americanbankingnews.com - May 10 at 12:30 PM |
| Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Cut to $168.00 by Analysts at HC Wainwright
www.americanbankingnews.com - May 8 at 11:25 PM |
| Madrigal Pharmaceuticals (NASDAQ:MDGL) Receives "Hold" Rating from Stifel Nicolaus
www.americanbankingnews.com - May 8 at 6:22 AM |
 | Madrigal Pharmaceuticals EPS misses by $0.40
seekingalpha.com - May 7 at 4:42 PM |
|
| Madrigal Pharmaceuticals Reports 2020 First Quarter Financial Results and Highlights
finance.yahoo.com - May 7 at 4:42 PM |
| Chardan Capital Begins Coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL)
www.americanbankingnews.com - May 5 at 8:17 PM |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Madrigal Pharmaceuticals, Inc. - MDGL
finance.yahoo.com - May 5 at 6:01 PM |
| Barclays issues flurry of healthcare ratings in premarket analyst action
seekingalpha.com - May 5 at 8:08 AM |
| Madrigal's Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - April 19 at 7:26 AM |
 | Madrigal Pharmaceuticals Inc.
www.barrons.com - April 18 at 7:55 PM |
 | Noteworthy Tuesday Option Activity: MDGL, DKS, EXPE
www.nasdaq.com - April 14 at 7:35 PM |
| Madrigal Pharma up 13% on positive data on NASH drug resmetirom
seekingalpha.com - April 14 at 9:34 AM |
| Madrigal MAESTRO Phase 3 NASH Trials Continue without Protocol Modifications; New Data Demonstrate that Reductions in Liver Fat Achieved by Resmetirom Predict NASH Resolution and Fibrosis Reduction
finance.yahoo.com - April 14 at 9:34 AM |
| Madrigal: A Stellar Stock For This Coronavirus Bear Market
seekingalpha.com - April 7 at 3:20 PM |
| Madrigal Pharmaceuticals Reports 2019 Fourth Quarter and Full Year Financial Results and Highlights
finance.yahoo.com - February 26 at 8:16 AM |
| Doubling Down On Madrigal Pharmaceuticals
seekingalpha.com - February 5 at 1:10 AM |
 | Why Madrigal Pharma Stock Could Still Double From NASH Development
247wallst.com - January 30 at 12:12 PM |
| Madrigal Pharmaceuticals, Inc. (MDGL): Hedge Fund Sentiment Unchanged
finance.yahoo.com - December 19 at 10:56 PM |
| Dosing underway in Madrigal's late-stage resmetirom study
seekingalpha.com - December 18 at 8:55 AM |
| Madrigal Pharmaceuticals Announces First Patient Dosed in MAESTRO-NAFLD-1, a Second Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Resmetirom (MGL-3196) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Presumed NASH (NASH/NAFLD (non-alcoholic fatty liver disease))
finance.yahoo.com - December 18 at 8:55 AM |
| Madrigal Pharmaceuticals investor selling large chunk of its stake
finance.yahoo.com - December 13 at 8:36 AM |
| Notable Two Hundred Day Moving Average Cross - MDGL
www.nasdaq.com - December 11 at 1:14 PM |
| Madrigal Pharmaceuticals prices 1.2M-share offering
seekingalpha.com - December 11 at 8:14 AM |
| Madrigal Pharmaceuticals Announces Pricing of Secondary Offering
finance.yahoo.com - December 11 at 12:27 AM |
| Madrigal launches 1.2M-share stock offering by current investor
seekingalpha.com - December 10 at 7:27 PM |
 | Madrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common Stock
www.marketwatch.com - December 10 at 7:27 PM |
| Madrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common Stock
finance.yahoo.com - December 10 at 7:27 PM |
| NASH Scorecard Year to Date: The Winners and the Losers
finance.yahoo.com - November 29 at 12:18 PM |
| Madrigal Pharmaceuticals Announces Publication in The Lancet of Positive Phase 2 Results for Resmetirom (MGL-3196) for the Treatment of Non-alcoholic Steatohepatitis (NASH)
finance.yahoo.com - November 11 at 5:54 PM |
| Madrigal Pharmaceuticals (MDGL) Shares Cross Above 200 DMA
www.nasdaq.com - November 11 at 12:54 PM |
| Madrigal Pharmaceuticals Reports 2019 Third Quarter Financial Results and Highlights
finance.yahoo.com - November 6 at 7:48 AM |
| Hedge Funds Are Dumping Madrigal Pharmaceuticals, Inc. (MDGL)
finance.yahoo.com - October 26 at 5:49 PM |
 | MDGL.O - Madrigal Pharmaceuticals Inc Profile | Reuters
www.reuters.com - October 6 at 7:33 PM |
| Madrigal: A Basic Overview
seekingalpha.com - September 26 at 4:16 PM |
| What Kind Of Share Price Volatility Should You Expect For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)?
finance.yahoo.com - September 19 at 8:24 PM |
| Potential Winner Of The First NASH Battle
seekingalpha.com - September 10 at 5:54 AM |
 | BRIEF-Madrigal Pharmaceuticals Reports 2019 Q2 Loss Per Share $1.28
www.msn.com - August 7 at 9:58 PM |
| Madrigal Pharmaceuticals Reports 2019 Second Quarter Financial Results and Highlights
finance.yahoo.com - August 7 at 11:08 AM |
| Madrigal: Weighed Down By Relevant Concerns Heading Into Pivotal Data
seekingalpha.com - July 31 at 10:46 PM |
| New President of R&D at Madrigal Pharma
seekingalpha.com - July 11 at 8:42 AM |
| Madrigal Pharmaceuticals Promotes Rebecca Taub, M.D., Chief Medical Officer and Executive Vice President of Research & Development, to Newly Created Position of President of Research & Development
finance.yahoo.com - July 11 at 8:42 AM |
| Have Insiders Been Buying Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares?
finance.yahoo.com - July 10 at 6:25 PM |
| Here’s What Hedge Funds Think About Madrigal Pharmaceuticals, Inc. (MDGL)
finance.yahoo.com - June 20 at 12:21 AM |
| Madrigal Pharmaceuticals to Present at Upcoming Investment Conferences
finance.yahoo.com - June 4 at 8:51 AM |
